April 24. 2022
Comirnaty (BioNTech and Pfizer) and Spikevax (Moderna) vaccines have ~4 times less reported suspected side effects compared to the Vaxzevria (AstraZeneca) and ~2 times less compared to the Jcovden (Janssen).
"The European Medicines Agency (EMA) monitors the safety of COVID-19 vaccines authorised in the European Union (EU) extremely carefully. This enables the detection of any rare side effects that may emerge once many millions of people are vaccinated. "
Safety of COVID-19 vaccines | European Medicines Agency (europa.eu)
- Comirnaty (BioNTech and Pfizer)
Status as of 24/04/2022
627,000,000 Doses given to people in the EU/EEA
743,735 Reports of suspected side effects in the EU/EEA (see www.adrreports.eu) = 0.118%
- Spikevax (Moderna)
Status as of 24/04/2022
155,000,000 Doses given to people in the EU/EEA
206,920 Reports of suspected side effects in the EU/EEA (see www.adrreports.eu) = 0.133%
- Jcovden (Janssen)
Status as of 24/04/2022
19,400,000 Doses given to people in the EU/EEA
48,410 Reports of suspected side effects in the EU/EEA (see www.adrreports.eu) = 0.249 %
- Vaxzevria (AstraZeneca)
Status as of 24/04/2022
69,000,000 Doses given to people in the EU/EEA
276,697 Reports of suspected side effects in the EU/EEA (see www.adrreports.eu) = 0.401 %